Review of Promising Off-Label Use of Deucravacitinib
Sign Up to like & getrecommendations! Published in 2025 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms26199447
Abstract: Tyrosine kinase 2 (TYK2) mediates the signaling pathways of proinflammatory cytokines such as interleukin (IL)-12, IL-23, and type I interferons (IFNs) and plays a pivotal role in the pathogenesis of psoriasis and various other immune-mediated… read more here.
Keywords: promising label; review promising; label use; use deucravacitinib ... See more keywords